Related Experiment Video
Updated: Oct 7, 2025

14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
Supramolecular Nanozyme-Based Cancer Catalytic Therapy
1Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Republic of Korea.
ACS Applied Bio Materials
|January 12, 2022
Summary
Supramolecular nanozymes offer an economical and stable alternative to natural enzymes for cancer catalytic therapy. These engineered nanomaterials effectively modulate the tumor microenvironment, showing promise for targeted cancer treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Nanozymes offer advantages over natural enzymes in cancer catalytic therapy due to their ease of preparation, cost-effectiveness, and enhanced stability.
- Supramolecular nanozymes represent a sophisticated approach, leveraging self-assembly for improved catalytic activity and biomedical applications.
- Modulating the tumor microenvironment, particularly redox state and reactive oxygen species, is crucial for effective cancer therapy.
Purpose of the Study:
- To review the construction, development, and applications of nanozymes and supramolecular nanozymes in cancer catalytic therapy.
- To highlight the materials, structures, catalytic mechanisms, and reactions of supramolecular nanozymes.
- To emphasize the potential of supramolecular nanozymes for selective, stable, and highly catalytic cancer treatment.
Main Methods:
- Review of existing literature on nanozymes and supramolecular nanozymes in cancer therapy.
- Analysis of supramolecular nanozyme architectures including nanoparticles, hydrogels, and nanovesicles.
- Discussion of catalytic mechanisms and reaction pathways relevant to cancer treatment.
Main Results:
- Supramolecular nanozymes demonstrate high catalytic efficiency and stability, outperforming natural enzymes in specific cancer therapy contexts.
- These nanozymes can effectively alter the redox balance and reactive oxygen species levels within the cancer environment.
- Various supramolecular nanozyme structures, such as nanoparticles and hydrogels, have been developed for biomedical applications.
Conclusions:
- Supramolecular nanozymes present a promising platform for cancer catalytic therapy due to their unique properties.
- Their selectivity, high catalytic capability, and stability offer a novel strategy for inhibiting cancer signaling pathways.
- Further research into supramolecular nanozymes could unlock new avenues for enzyme-mimicking therapeutic strategies.
Related Concept Videos
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Combination Therapies and Personalized Medicine
5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Electron Transport Chain: Complex I and II
15.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.2K

